SCHEMBL19330152

SCHEMBL19330152

COC(=O)c1cc(OC)nc(OC)c1OC

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.55
KDM4E B2RXH2 5/20 0.55
HPGD P15428 4/20 0.51
L3MBTL1 Q9Y468 1/20 0.50
NPSR1 Q6W5P4 1/20 0.47
KMT2A Q03164 1/20 0.47
POLB P06746 4/20 0.46
TDP1 Q9NUW8 1/20 0.46
GAA P10253 1/20 0.45
SMN1; SMN2 Q16637 3/20 0.43
CYP1A2 P05177 1/20 0.43
RAB9A P51151 2/20 0.41
NPC1 O15118 1/20 0.41
HSD17B10 Q99714 3/20 0.41
USP2 O75604 1/20 0.41
TSHR P16473 2/20 0.40
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19330148 0.87 TDP1 (0.61) ALDH1A1KDM4EHPGDL3MBTL1POLB
SCHEMBL6560149 0.83 KDM4E (0.51) ALDH1A1KDM4EHPGDL3MBTL1KMT2A
SCHEMBL19330334 0.79 POLB (0.41) ALDH1A1KDM4EHPGDL3MBTL1KMT2A
SCHEMBL30701127 0.79 POLB (0.41) ALDH1A1KDM4EHPGDL3MBTL1KMT2A
SCHEMBL6559464 0.79 ALDH1A1 (0.51) ALDH1A1KDM4EHPGDL3MBTL1NPSR1
SCHEMBL11605385 0.76 TDP1 (0.71) ALDH1A1KDM4EHPGDL3MBTL1KMT2A
SCHEMBL1901245 0.76 ALDH1A1 (0.47) ALDH1A1KDM4EHPGDL3MBTL1KMT2A
SCHEMBL30701075 0.76 ALDH1A1 (0.43) ALDH1A1KDM4EKMT2APOLBTDP1
SCHEMBL19330612 0.76 ALDH1A1 (0.43) ALDH1A1KDM4EKMT2APOLBTDP1
SCHEMBL6559448 0.74 ATR (0.50) ALDH1A1KDM4EHPGDL3MBTL1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109069514-B Antibacterial compound and application thereof 结核病药物开发全球联盟公司 2023-12-29 CN disclosed
EP-4148053-A1 ANTIBACTERIAL COMPOUNDS AND USES THEREOF The Global Alliance for TB Drug Development, Inc. (US) 2023-03-15 EP disclosed
EP-3426255-B1 ANTIBACTERIAL COMPOUNDS AND USES THEREOF GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC (US) 2022-11-30 EP disclosed
EP-3426255-B1 ANTIBACTERIAL COMPOUNDS AND USES THEREOF GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC (US) 2022-11-30 EP disclosed
US-10981891-B2 Antibacterial compounds and uses thereof THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC. (US) 2021-04-20 US disclosed
US-10981891-B2 Antibacterial compounds and uses thereof THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC. (US) 2021-04-20 US disclosed
US-20200039955-A1 ANTIBACTERIAL COMPOUNDS AND USES THEREOF THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC. 2020-02-06 US disclosed
US-20200039955-A1 ANTIBACTERIAL COMPOUNDS AND USES THEREOF THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC. 2020-02-06 US disclosed
US-10508097-B2 Antibacterial compounds and uses thereof THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC. (US) 2019-12-17 US disclosed
US-10508097-B2 Antibacterial compounds and uses thereof THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC. (US) 2019-12-17 US disclosed
US-20190071417-A1 ANTIBACTERIAL COMPOUNDS AND USES THEREOF THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC. 2019-03-07 US disclosed
US-20190071417-A1 ANTIBACTERIAL COMPOUNDS AND USES THEREOF THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC. 2019-03-07 US disclosed
EP-3426255-A1 ANTIBACTERIAL COMPOUNDS AND USES THEREOF The Global Alliance for TB Drug Development, Inc. (US) 2019-01-16 EP disclosed
WO-2017155909-A1 ANTIBACTERIAL COMPOUNDS AND USES THEREOF THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC. (US) 2017-09-14 WO disclosed
WO-2017155909-A1 ANTIBACTERIAL COMPOUNDS AND USES THEREOF THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC. (US) 2017-09-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10981891-B2 Antibacterial compounds and uses thereof CFTR, SQOR, NQO1 ALDH1A1 518/4885KDM4E 3810/4885HPGD 966/4885
US-20200039955-A1 ANTIBACTERIAL COMPOUNDS AND USES THEREOF CFTR, SQOR, NQO1 ALDH1A1 518/4885KDM4E 3810/4885HPGD 966/4885
US-10508097-B2 Antibacterial compounds and uses thereof CFTR, SQOR, NQO1 ALDH1A1 518/4885KDM4E 3810/4885HPGD 966/4885
US-20190071417-A1 ANTIBACTERIAL COMPOUNDS AND USES THEREOF CFTR, SQOR, NQO1 ALDH1A1 518/4885KDM4E 3810/4885HPGD 966/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.